TG-89

CAS No. 936091-56-4

TG-89( —— )

Catalog No. M33687 CAS No. 936091-56-4

TG-89 is an inhibitor of JAK2, JAK3, RET and FLT3, and has an IC50 value of 11.2 μM against JAK2, showing anticancer activity in the treatment of ovarian and cervical cancer.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 85 Get Quote
5MG 149 Get Quote
10MG 237 Get Quote
25MG 382 Get Quote
50MG 544 Get Quote
100MG 718 Get Quote
500MG 1431 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    TG-89
  • Note
    Research use only, not for human use.
  • Brief Description
    TG-89 is an inhibitor of JAK2, JAK3, RET and FLT3, and has an IC50 value of 11.2 μM against JAK2, showing anticancer activity in the treatment of ovarian and cervical cancer.
  • Description
    JAK-IN-32 (XC) is a bi-aryl meta-pyrimidine inhibitor of JAK kinase.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Angiogenesis
  • Target
    FLT
  • Recptor
    FLT | JAK | c-RET
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    936091-56-4
  • Formula Weight
    510.65
  • Molecular Formula
    C26H34N6O3S
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    Cc1cnc(Nc2cccc(CN3CCOCC3)c2)nc1Nc1cccc(c1)S(=O)(=O)NC(C)(C)C
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Glenn Noronha, et al. Bi-aryl meta-pyrimidine inhibitors of kinases. Patent. US20110212077A1.
molnova catalog
related products
  • FLT3-IN-2

    FLT3-IN-2 is a FLT3 inhibitor with IC50 of < 1 μM.

  • MRX-2843

    MRX-2843 is a potent and orally active inhibitor of MERTK and FLT3(IC50s of 1.3 nM and 0.64 nM, respectively).

  • Emavusertib

    Emavusertib is a potent IRAK4/FLT3 inhibtor. CA-4948 with anti-tumor activity.